Will AUCATZYL® (obe-cel) achieve $100 million in sales by end of Q1 2025? | Binary | | | 1 month ago | |
Will Autolus stock increase by 20% or more by end of 2024? | Binary | | | 1 month ago | |
What major industry award will AUCATZYL® (obe-cel) win in 2025? | Categorical | | | 1 month ago | |
Will Autolus announce AUCATZYL® (obe-cel) expansion to other cancers by end of 2024? | Binary | | | 1 month ago | |
Which company will first receive FDA approval for a competitor to AUCATZYL® (obe-cel) by end of 2025? | Categorical | | | 1 month ago | |
Will Autolus announce a partnership or acquisition related to AUCATZYL® (obe-cel) by mid-2025? | Categorical | | | 1 month ago | |
Will Autolus Therapeutics enter a partnership or be acquired by end of 2025? | Binary | | | 2 months ago | |
Will Autolus Therapeutics' stock rise 20%+ by end of Q1 2025 post-FDA approval? | Binary | | | 2 months ago | |
Will Aucatzyl lead US market in r/r B-ALL treatments by end of 2025? | Binary | | | 2 months ago | |
Which treatment will have the largest market share for r/r B-ALL in US by end of 2025? | Categorical | | | 2 months ago | |
What will be Autolus' revenue growth rate in 2025 post-Aucatzyl approval? | Categorical | | | 2 months ago | |
How many CAR-T therapies will FDA approve in 2025 including Aucatzyl? | Categorical | | | 2 months ago | |
